Evalution of Immunogenicity, Safety and Booster Response of a Rabies Vaccine Administered Concomitantly With Japanese Encephalitis Vaccine in Toddlers

Inclusion Criteria: * Male and female 12-18 months old toddlers if they * are in good health at time of entry into the study * are available for all the visits scheduled in the study * have been granted a written informed consent, signed by their parents Exclusion Criteria: * a history of rabies immunization * a history of Japanese encephalitis immunization or disease * a significant acute or chronic infectious disease at the time of enrollment * fever ≥ 38.0°C (axillary) or/and significant acute or chronic infection requiring antibiotic or antiviral therapy within the past 7 days before enrollment * being under treatment with corticosteroids, immunosuppressive drugs or other specific anti-inflammatory drugs or having taken chloroquine during the two months period before enrollment * administration of any vaccine within the past 14 days before enrollment * known immunodeficiency or an autoimmune disease * history of allergy to eggs, egg products * known hypersensitivity to neomycin, tetracycline, amphotericin-B * planned surgery during the study period * being enrolled in any other investigational trial contemporaneously * the family plans to leave the area of the study site before the end of study period * history of febrile convulsions * history of wheezing